Access to medicines

Millions of poor people around the world fall sick and die because they lack access to the diagnostics, vaccines, and medicines needed to identify, prevent, or treat debilitating diseases.

Oxfam is working in partnership with other organizations to draw attention to two critical barriers that bar access to medicines in developing countries. First, we are publicizing the lack of innovation for new diagnostics, vaccines, and medicines. Second, we are fighting language in international trade agreements that would prevent poor people from accessing the patented medicines they desperately need but cannot afford.

Tell Congress: Don't cut aid. It's working.
American poverty-fighting assistance saves lives and helps millions of people lift themselves out of poverty, all for less than 1% of the federal budget. Cutting aid won't close the budget gap -- but it will close the door on a better future for the world's most vulnerable communities. Speak up with us now: Tell Congress to oppose any cuts to lifesaving foreign aid.
Support effective, efficient aid programs – they save lives.
Right now, forty percent of the world’s population – more than 2.5 billion people – live in poverty, struggling to survive on less than $2 per day. The persistence of global poverty poses a challenge to the security, prosperity and values of the United States. Cuts to the world's most vulnerable communities have real impacts. Tell Congress we won't stand by while they make cuts that will cost lives.
More actions
Public Health at Risk
Will US trade policy undermine global access to affordable medicines?
In war-torn Darfur, a stove with a mission
For the women of Darfur who live in camps for displaced people, simply feeding a family can present extraordinary risks.
Saving lives through country ownership
Three steps for President Obama's Global Health Initiative to succeed
Ending the R&D Crisis in Public Health
Investing for Life
Meeting poor people's needs for access to medicines through responsible business practices
All Costs, No Benefits
How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines
Patents versus Patients
Five years after the Doha Declaration
Song of the Sirens
Why the US–Andean FTAs undermine sustainable development and regional integration
Public Health at Risk
A US Free Trade Agreement could threaten access to medicines in Thailand
More research
A very good week
During the MDG summit in September, we saw huge progress on the commitment to reduce hunger and poverty--and President Obama announced the first-ever US global development policy.
More multimedia

Features Subscribe | View All

Top 10 things you need to know about Oxfam

Top 10 things you need to know about Oxfam

Here are the most important facts about Oxfam America: what we do, how we do it, and how you can get involved in our mission.

Read more

A simple guide to patents and trademarks

A simple guide to patents and trademarks

Patents and trademarks—otherwise known as IP (intellectual property)—and why it is so important for poor countries.

Read more

Access to medicines means access to life

Access to medicines means access to life

During a US tour, Thai activists explain how a trade agreement could limit access to affordable HIV and AIDS drugs.

Read more

» More stories «
Document Actions